New pill tested to fight Diabetes-Related vision loss

This study tested an oral supplement called Nuvastatic to see if it could help control early-stage diabetic retinopathy, a common diabetes complication that damages the retina and can lead to vision loss. It involved 100 adults with type 2 diabetes who had this early eye disease but not a more severe form of swelling in the center of the retina. The goal was to see if the supplement could reduce retinal thickness and improve certain protein markers, potentially offering a new way to manage the condition.